• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team features original research articles on readmissions after atrial septal defect (ASD) closure and socioeconomic disparities in access to the Watchman device in patients with atrial fibrillation (AF).

• share
• favorite_border

The CTO Summit 2019 is a two-day course featuring the latest research, advanced techniques, and state-of-the-art technologies for chronic total occlusions. This year’s conference will emphasize practical hands-on training and will feature 12 live case transmissions conducted by the most skilled operators in CTO stenting with real-time analysis by world-renowned faculty. Sessions will cover a broad range of topics covering operator techniques, guidewire technology, and other adjunctive devices.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) will salute renowned cardiologist, Dr. Clyde Yancy for his extraordinary contributions to the field. His vital work in improving access to healthcare and cardiovascular outcomes for underserved populations will be recognized, along with his tireless efforts to promote health equity by mentoring and encouraging young people to pursue careers in medicine.

• share
• favorite_border

The first randomized trial of its kind was unable to establish non-inferiority of oral anticoagulation (OAC) alone to combined OAC and a single antiplatelet agent (APT) in patients with atrial fibrillation (AF) and stable coronary artery disease beyond one year after stent implantation.

• share
• favorite_border

Results from the Lipid-Rich Plaque (LRP) study demonstrate the correlation between the presence of non-flow-limiting, non-intervened upon, lipid-rich plaques detected by NIRS-IVUS imaging and the development of a major adverse cardiac event (MACE) from a de novo culprit lesion at both the patient level (vulnerable patients) and segment level (vulnerable plaques) within 24 months post intravascular imaging.

• share
• favorite_border

The first study designed to determine the benefits of intravascular ultrasound (IVUS) guidance over angiography guidance during drug-eluting stent (DES) implantation in all-comer patients found that IVUS improved clinical outcomes by lowering the rate of target vessel failure at one year.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that Aria CV has won the TCT 2018 Shark Tank Competition which took place during the Transcatheter Cardiovascular Therapeutics (TCT) 2018, the world’s premier educational meeting specializing in interventional cardiovascular medicine. The winner was also presented with the Jon DeHaan Foundation Award for Interventional Innovation today in the Main Arena of the San Diego Convention Center.

• share
• favorite_border

Data presented today from the randomized COAPT trial, which have the potential to significantly change current clinical practice, found that patients with heart failure and secondary mitral regurgitation (MR) who remained symptomatic despite maximally tolerated medical therapy demonstrated reduced rates of hospitalizations and death, as well as improved quality-of-life and functional capacity after being treated with the transcatheter MitraClip device.

• share
• favorite_border

The first randomized study to compare general versus local anesthesia during transcatheter aortic valve replacement (TAVR) in patients with intermediate to high surgical risk found local anesthesia to be both safe and effective. In addition, the study found that a current generation balloon-expandable valve had similar outcomes to a current generation self-expanding one.

• share
• favorite_border

This first randomized clinical study of a polymer-coated zotarolimus-eluting stent (Resolute Onyx) that utilizes a novel thin-strutted metallic platform allowing for better x-ray visibility was shown to be non-inferior to an ultrathin-strutted bioresorbable polymer-coated sirolimus-eluting stent (Orsiro) that uses a cobalt-chromium strut platform.

• share
• favorite_border

The first large, randomized trial comparing a novel polymer-free amphilimus-eluting stent to the latest-generation permanent polymer drug-eluting stent found that the polymer-free stent was clinically safe and effective.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and late-breaking clinical science that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place September 21-25 in San Diego, California.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) has announced the 15 late-breaking trials and 12 late-breaking clinical science presentations that will be reported at the Transcatheter Cardiovascular Therapeutics (TCT) 2018 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place September 21 – 25, 2018 at the San Diego Convention Center in San Diego, California.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that its premier translational research facility, the CRF Skirball Center for Innovation (SCI), is partnering with Siemens Healthineers to advance their imaging capabilities for structural heart disease research. SCI is dedicated to guiding early ideas and innovations in cardiology through comprehensive preclinical research programs to introduce practical clinical therapies to patients. As part of this collaboration, SCI will now offer a Siemens Healthineers SOMATOM Definition Flash CT scanner, which will help expand SCI’s research capabilities and maximize efficiencies for its sponsors.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “Healthy Aging: What Women Need to Know About Heart Health at Every Age,” on Thursday, June 14, 2018 in New York City. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing women with practical ways to keep their heart healthy at all stages of life. Attendees will learn about lifestyle changes, risk factors, and treatment options for coronary artery disease and aortic stenosis, two conditions that develop as you age.

• share
• favorite_border

New this year, Transcatheter Valve Therapies (TVT) 2018, featuring practical clinical workshops, innovation sessions, and live case demonstrations, is the first part of a comprehensive congress called The Structural Heart Disease Summit. It will be followed by a live case demonstration course on LAA and PFO Closure.

• share
• favorite_border

A novel non-hyperemic index of coronary stenosis severity called resting full-cycle ratio (RFR) was found to be diagnostically equivalent to instantaneous wave-free ratio (iFR) in the VALIDATE RFR study. The results were presented today at EuroPCR, the annual meeting of the European Association of Percutaneous Cardiovascular Interventions, by Ziad A. Ali, MD, DPhil, and simultaneously published in EuroIntervention.

• share
• favorite_border

Media registration is now open online for TCT 2018 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine, attracting more than 10,000 attendees from 90 countries all over the world.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” for the New York City community on Wednesday, February 7, 2018. The seminar, part of a series of Mini-Med Schools conducted by the CRF Women’s Heart Health Initiative, will focus on providing attendees a deeper understanding of diabetes and its connection with cardiovascular disease.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team is now available online.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) will hold a free seminar, “The Link Between Diabetes & Your Heart,” on Wednesday, February 7, 2018 in New York City. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing attendees a deeper understanding of diabetes and its connection with cardiovascular disease.

• share
• favorite_border

Results from the prospective, multicenter, randomized investigator-initiated REDUCE trial were reported today at the 29th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.

• share
• favorite_border

The first trial to evaluate the safety of dual antiplatelet therapy (DAPT) for less than 12 months in ST-elevation myocardial infarction (STEMI) found six months of DAPT was non-inferior to 12 months of DAPT among patients treated with second-generation drug-eluting stents (DES).

• share
• favorite_border

Elderly patients undergoing PCI often receive bare-metal stents (BMS) instead of drug-eluting stents (DES) to shorten the duration of dual antiplatelet therapy (DAPT) and reduce bleeding risk. However, results from the SENIOR trial found that compared with BMS, shorter DAPT combined with the Synergy bioabsorbable polymer DES leads to less adverse events without increasing bleeding risk.

• share
• favorite_border

Thirty-day results from ABSORB IV, the largest randomized everolimus-eluting bioresorbable vascular scaffold (BVS) trial to date, found BVS to be noninferior to a cobalt-chromium everolimus-eluting stent (CoCr-EES) for target lesion failure (TLF).

• share
• favorite_border

Analysis of the PARTNER 2A trial and the SAPIEN-3 Intermediate Risk registry found transcatheter aortic valve replacement (TAVR) to be highly cost-effective compared with surgical aortic valve replacement (SAVR) in intermediate surgical risk patients with aortic stenosis.

• share
• favorite_border

A large-scale randomized trial examining the double kissing (DK) crush two-stent technique compared with provisional stenting (PS) in the treatment of true distal bifurcation lesions of the left main artery, found that the DK crush technique was associated with a lower rate of target lesion failure at one year.

• share
• favorite_border

Results from the prospective, randomized, multicenter CULPRIT-SHOCK trial found that an initial strategy of culprit lesion only percutaneous coronary intervention (PCI) reduces the composite of 30-day mortality and/or severe renal failure in patients with multivessel disease and cardiogenic shock complicating acute myocardial infarction.

• share
• favorite_border

New study results from the EXCEL trial comparing the quality of life (QoL) of patients with left main coronary artery disease (LMCAD) receiving percutaneous coronary intervention (PCI) versus coronary artery bypass graft surgery (CABG) found significant and similar QoL improvement at three years, although a greater benefit was observed with PCI at one month.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that the second issue of Structural Heart: The Journal of the Heart Team is now available online.

• share
• favorite_border

The Geoffrey O. Hartzler Master Clinical Operator Award will be presented to Alec Vahanian, MD, in a ceremony on October 31st at the 29th Transcatheter Cardiovascular Therapeutics (TCT) conference in Denver, Colorado. TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF). The award is given each year to a physician who has advanced the field of interventional cardiovascular medicine through technical excellence and innovation. TCT Directors, Martin B. Leon, MD, and Gregg W. Stone, MD, will present the award.

• share
• favorite_border

Internationally renowned cardiologist, Elazer Edelman, MD, PhD, will be presented with the TCT Career Achievement Award on Monday, October 30th during the 29th Transcatheter Cardiovascular Therapeutics (TCT) conference in Denver, Colorado. TCT is the annual scientific symposium of the Cardiovascular Research Foundation (CRF). TCT Directors, Martin B. Leon, MD, and Gregg W. Stone, MD, will present the award.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) has announced the press conference schedule for late-breaking trials and first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place October 29 – November 2 in Denver, Colorado.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) has announced the 12 late-breaking trials and 16 first report investigations that will be presented at the Transcatheter Cardiovascular Therapeutics (TCT) 2017 scientific symposium. TCT, the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place October 29 – November 2, 2017 at the Colorado Convention Center in Denver, Colorado.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) today announced the appointment and promotion of Juan F. Granada, MD, as the foundation’s President and Chief Executive Officer. Dr. Granada was also appointed to CRF’s Board of Directors. A renowned leader in cardiology, he joined CRF in 2007 and served as Executive Director and Chief Innovation Officer at the CRF Skirball Center for Innovation.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that the first issue of Structural Heart: The Journal of the Heart Team is now available online.

• share
• favorite_border

Media registration is open online for TCT 2017 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world’s premier educational meeting specializing in interventional cardiovascular medicine.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) will hold a free seminar “Broken Hearts: Living with Heart Failure” on Tuesday, June 6, 2017 for heart failure patients and caregivers at New York-Presbyterian Hospital. The seminar, part of a series of Mini-Med School seminars conducted by the CRF Women’s Heart Health Initiative, will focus on providing both patients and caregivers a deeper understanding of heart failure, its symptoms, and treatment options.

• share
• favorite_border

The agenda for the TVT (Transcatheter Valve Therapies) is now available online: http://www.crf.org/tvt/the-conference/agenda. TVT 2017 is a practical three-day course featuring the latest research and state-of-the-art techniques for transcatheter aortic and mitral valve therapies. For 10 years, TVT has provided healthcare professionals with the latest advances, tools, and techniques for the treatment of valvular heart disease using nonsurgical procedures.

• share
• favorite_border

CRF will hold a free seminar, “Broken Hearts: Living with Heart Failure,” on Tuesday, June 6, 2017 for heart failure patients and caregivers at NewYork-Presbyterian Hospital. The seminar will focus on providing both patients and caregivers a deeper understanding of heart failure, its symptoms, and treatment options.

• share
• favorite_border

Media registration is now open online for TCT 2017 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF).

• share
• favorite_border

The CRF Women’s Heart Health Initiative is holding a yoga fundraiser on Tuesday, April 25th led by noted expert and senior instructor Tanya Boulton at Pure Yoga West in New York City. This is a wonderful opportunity to reduce stress and take care of your heart while raising money for heart disease research and education for women.

• share
• favorite_border

For 10 years, TVT (Transcatheter Valve Therapies) has provided healthcare professionals with the latest advances, tools, and techniques for the treatment of valvular heart disease using nonsurgical procedures. The first TVT was held in 2008 and has since become the preeminent conference for transcatheter valve therapies. TVT 2017 is a practical three-day course featuring the latest research and state-of-the-art techniques for transcatheter aortic and mitral valve therapies.

• share
• favorite_border

CRF’s next Mini-Med School for Women will cover the role stress plays in heart disease, and ways to manage stress for optimal health. The seminar is part of the CRF Women’s Heart Health Initiative which aims to reduce gender disparity in cardiovascular care through research and education. These Mini-Med School seminars feature leading experts who give New York area women the tools to take better care of themselves and their loved ones.

• share
• favorite_border

Faculty and fellows from the Cardiovascular Research Foundation (CRF) will be presenting abstracts at the American College of Cardiology 66th Annual Scientific Session taking place March 17-19, 2017 at the Walter E. Washington Convention Center in Washington, DC. They will be sharing the latest data on drug-eluting stents, left main coronary disease, imaging technologies, dual antiplatelet therapy and other topics.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) is pleased to announce that the submission site is now open for Structural Heart: The Journal of the Heart Team at https://mc.manuscriptcentral.com/structuralheartj. Structural Heart is a new journal that will focus on diagnosing and treating diseases of the heart valves, myocardium and great vessels, as well as congenital heart disease, and the importance of the Heart Team in this process.

• share
• favorite_border

CRF’s next Mini-Med School for Women will cover the role stress plays in heart disease, and ways to manage stress for optimal health. The seminar is part of the CRF Women’s Heart Health Initiative which aims to reduce gender disparity in cardiovascular care through research and education. These Mini-Med School seminars feature leading experts who give New York area women the tools to take better care of themselves and their loved ones.

• share
• favorite_border

The Chronic Total Occlusion (CTO) Summit 2017 will feature the latest research and techniques available for interventional cardiologists in this emerging subspecialty of complex coronary artery disease. Now in its 14th year, the two-day course will take place February 23-24 at the New York Marriott Marquis.

• share
• favorite_border

The Cardiovascular Research Foundation (CRF) announced that it will launch a new international journal focusing on the diagnosis and treatment of structural heart disease and the importance of the heart team in managing these disorders.

• share
• favorite_border

Results from a randomized, multicenter trial failed to show non-inferiority of hybrid, ultra-thin strut sirolimus-eluting stents (Osiro SES) with a biodegradable polymer compared to thin-strut everolimus-eluting stents (Xience EES) with a durable polymer in terms of in-segment late lumen loss in successfully treated chronic total occlusions. In addition, although the rate of binary restenosis was low overall in this complex lesion subset, it was higher with the Osirio SES compared with the Xience EES.